“…Low-grade dysplasia may develop into high-grade dysplasia and intramucosal adenocarcinoma (7). High-grade dysplasia progresses into carcinoma in 15%-20% of patients (3). Indicators of neoplasia include biomarkers (ornithine decarboxylase, carcinoembryonic antigen, mucus abnormalities), chromosomal abnormalities (tumor suppressor genes, oncogenes), flow cytometry (aneuploidy, cellular proliferation), and growth regulatory factors.…”